LON:DEST - Destiny Pharma Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Destiny Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 32 0.00 (0.00 %) (As of 04/1/2020 04:00 PM ET) Add Compare Today's Range 32Now: GBX 32▼ 3350-Day Range 32MA: GBX 35.50▼ 37.5052-Week Range 32Now: GBX 32▼ 85Volume643 shsAverage Volume4,205 shsMarket Capitalization£14.04 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsInsider TradesHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Destiny Pharma plc, a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of novel medicines for the treatment of infectious diseases in the United Kingdom. It is involved in developing XF-73 Nasal for the treatment of post-surgical staphylococcal infections; XF-73 Throat for the treatment of staphylococcal hospital/ventilator pneumonia infections; XF-70 Dermal for the treatment of skin burn wound infections of antibiotic resistant bacteria; and XF-70 Lung for the treatment of bacterial biofilm-associated infections. The company has collaboration agreement with China Medical System Holdings Limited; and research collaboration with the University of Southampton for targeting infections in diabetic foot ulcers and cystic fibrosis. The company was incorporated in 1996 and is headquartered in Brighton, the United Kingdom.Read More Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:DEST Previous Symbol CUSIPN/A CIKN/A Webhttp://www.destinypharma.com/ Phone+44-1273-704440Debt Debt-to-Equity RatioN/A Current Ratio37.14 Quick Ratio36.48Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 20.48 per share Price / Cash Flow1.56 Book ValueGBX 23.50 per share Price / Book1.36Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares43,865,200Market Cap£14.04 million Next Earnings DateN/A OptionableOptionable Receive DEST News and Ratings via Email Sign-up to receive the latest news and ratings for DEST and its competitors with MarketBeat's FREE daily newsletter. LSE:DEST Rates by TradingView Destiny Pharma (LON:DEST) Frequently Asked Questions How has Destiny Pharma's stock been impacted by COVID-19 (Coronavirus)? Destiny Pharma's stock was trading at GBX 35.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, DEST stock has decreased by 9.9% and is now trading at GBX 32. View which stocks have been mosted impacted by Coronavirus. How were Destiny Pharma's earnings last quarter? Destiny Pharma PLC (LON:DEST) announced its quarterly earnings results on Tuesday, April, 9th. The company reported ($11.90) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($16.20) by $4.30. View Destiny Pharma's earnings history. Has Destiny Pharma been receiving favorable news coverage? Media stories about DEST stock have been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Destiny Pharma earned a daily sentiment score of 0.6 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutDestiny Pharma. Who are some of Destiny Pharma's key competitors? Some companies that are related to Destiny Pharma include Immutep (IMM), Altimmune (ALT), Asterias Biotherapeutics (AST), AquaBounty Technologies (AQB), Covalon Technologies (COV), Medlab Clinical (MDC), Oxford Biodynamics (OBD), Immunoprecise Antibodies (IPA), Orthocell (OCC), Zelda Therapeutics (ZLD), Verona Pharma (VRP), Tiziana Life Sciences (TILS), Equillium (EQ), Acasti Pharma (ACST) and OptiBiotix Health (OPTI). What other stocks do shareholders of Destiny Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Destiny Pharma investors own include African Potash (AFPO), FDM Group (FDM), LiDCO Group (LID), NCC Group (NCC), Photo-Me International (PHTM), Royal Dutch Shell (RDSB), Satellite Solutions Worldwide (SAT), Shanta Gold (SHG), Somero Enterprises (SOM) and Greencoat UK Wind (UKW). Who are Destiny Pharma's key executives? Destiny Pharma's management team includes the following people: Mr. Neil Robert Clark, CEO & Director (Age 56)Dr. William Guy Love, Founder, Chief Scientific Officer & Director (Age 56)Mr. Shaun Claydon, CFO, Company Sec. & Director (Age 51)Dr. Jesús M González Moreno, Chief Medical Officer What is Destiny Pharma's stock symbol? Destiny Pharma trades on the London Stock Exchange (LON) under the ticker symbol "DEST." How do I buy shares of Destiny Pharma? Shares of DEST and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Destiny Pharma's stock price today? One share of DEST stock can currently be purchased for approximately GBX 32. How big of a company is Destiny Pharma? Destiny Pharma has a market capitalization of £14.04 million. View additional information about Destiny Pharma. What is Destiny Pharma's official website? The official website for Destiny Pharma is http://www.destinypharma.com/. How can I contact Destiny Pharma? Destiny Pharma's mailing address is Sussex Innovation Centre Science Park Square, Falmer, BRIGHTON, BN1 9SB, United Kingdom. The company can be reached via phone at +44-1273-704440. MarketBeat Community Rating for Destiny Pharma (LON DEST)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 75 (Vote Outperform)Underperform Votes: 77 (Vote Underperform)Total Votes: 152MarketBeat's community ratings are surveys of what our community members think about Destiny Pharma and other stocks. Vote "Outperform" if you believe DEST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DEST will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/1/2020 by MarketBeat.com StaffFeatured Article: How is Preferred Stock Different from Common Stock?
